QIANA WITHERS: Open Payments
NPI 1164099685 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,441 in 98 payments from 16 companies in 2025. Trend: 2023 $27 · 2024 $836 · 2025 $1,441
Food & beverage: $1,347Education: $94
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 29 | $348 |
| Janssen Biotech, Inc. | 16 | $302 |
| PFIZER INC. | 16 | $177 |
| ABBVIE INC. | 14 | $148 |
| Regeneron Healthcare Solutions, Inc. | 5 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| QOL Medical, LLC | 2 | $48 |
| Madrigal Pharmaceuticals | 2 | $46 |
| Abbott Laboratories | 2 | $45 |
| Exact Sciences Corporation | 3 | $44 |
Products named: TREMFYA, XIFAXAN, VELSIPITY, DUPIXENT, RINVOQ, RELISTOR, ENTYVIO, Sucraid.
Industry payments across NY — which companies pay providers there.
